Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice

BACKGROUND: NLR family pyrin domain containing 3 (NLRP3) inflammasome has been implicated in the development of atherosclerosis and several studies have suggested that inhibiting NLRP3 inflammasome could be a potential therapeutic approach to treat atherosclerosis. Baicalin is a flavone glycoside wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jingfei, Wang, Zhengtang, Yuan, Zhilu, Lv, Shuzhen, Su, Qingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919226/
https://www.ncbi.nlm.nih.gov/pubmed/33269624
http://dx.doi.org/10.1177/1479164120977441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919226/
https://www.ncbi.nlm.nih.gov/pubmed/33269624
http://dx.doi.org/10.1177/1479164120977441

Ejemplares similares